Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Maravai Lifesciences Holdings Inc Cl A (MRVI)

Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,852,818
  • Shares Outstanding, K 251,400
  • Annual Sales, $ 288,950 K
  • Annual Income, $ -119,030 K
  • 60-Month Beta 0.01
  • Price/Sales 6.35
  • Price/Cash Flow 80.36
  • Price/Book 2.42
Trade MRVI with:

Options Overview Details

View History
  • Implied Volatility 92.75% ( -1.72%)
  • Historical Volatility 56.64%
  • IV Percentile 67%
  • IV Rank 47.00%
  • IV High 166.12% on 11/16/23
  • IV Low 27.70% on 07/18/23
  • Put/Call Vol Ratio 0.83
  • Today's Volume 77
  • Volume Avg (30-Day) 81
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 3,030
  • Open Int (30-Day) 6,818

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 5
  • High Estimate -0.05
  • Low Estimate -0.06
  • Prior Year 0.03
  • Growth Rate Est. (year over year) -300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.19 +7.37%
on 04/19/24
8.92 -13.45%
on 04/04/24
-1.04 (-11.87%)
since 03/22/24
3-Month
5.05 +53.02%
on 02/22/24
8.92 -13.45%
on 04/04/24
+1.42 (+22.54%)
since 01/23/24
52-Week
4.52 +70.80%
on 11/09/23
16.62 -53.55%
on 05/16/23
-6.74 (-46.61%)
since 04/21/23

Most Recent Stories

More News
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2023.

MRVI : 7.72 (+4.75%)
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2023.

MRVI : 7.72 (+4.75%)
Stock Index Futures Plunge as China Trade Data Disappoints, Moody's Downgrades U.S. Banks

September S&P 500 futures (ESU23) are down -0.45%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.49% this morning as fresh worries about China’s economic rebound and the state of U.S. banks...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
BRK.A : 615,175.00 (-0.34%)
SOVO : 22.98 (+0.13%)
TSN : 60.98 (+0.61%)
TSLA : 144.68 (+1.85%)
LLY : 745.69 (+1.96%)
UPS : 148.87 (+2.41%)
ZTS : 149.56 (+2.76%)
DUK : 98.20 (+0.08%)
GLEN.LN : 468.500 (-1.35%)
CHGG : 6.83 (+0.15%)
Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2023.

MRVI : 7.72 (+4.75%)
Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript

MRVI earnings call for the period ending March 31, 2023.

MRVI : 7.72 (+4.75%)
Maravai LifeSciences Holdings, Inc. (MRVI) Lags Q1 Earnings and Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of -25% and 0.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

MRVI : 7.72 (+4.75%)
EGRX : 4.77 (+4.84%)
Vapotherm (VAPO) Reports Q1 Loss, Lags Revenue Estimates

Vapotherm (VAPO) delivered earnings and revenue surprises of -9.76% and 4.39%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VAPO : 1.2660 (+0.48%)
MRVI : 7.72 (+4.75%)
2 Top Biotech Stocks to Buy In March and Hold Forever

Their price is right, and their future is bright.

MRNA : 107.89 (+3.28%)
MRVI : 7.72 (+4.75%)
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential

There isn't much that's stopping them from penetrating their markets globally.

INMD : 17.37 (+1.34%)
MRVI : 7.72 (+4.75%)
Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2022.

MRVI : 7.72 (+4.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and...

See More

Key Turning Points

3rd Resistance Point 8.82
2nd Resistance Point 8.46
1st Resistance Point 8.09
Last Price 7.72
1st Support Level 7.36
2nd Support Level 7.00
3rd Support Level 6.63

See More

52-Week High 16.62
Fibonacci 61.8% 12.00
Fibonacci 50% 10.57
Fibonacci 38.2% 9.14
Last Price 7.72
52-Week Low 4.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar